Skip to main content.
Menu

State Prison Officials: Receiver's Valley Fever Policy 'Premature'

Prisoners at Risk

Fellowship Story Showcase

State Prison Officials: Receiver's Valley Fever Policy 'Premature'

Reporting on Health Collaborative
Wednesday, May 8, 2013

By TRACY WOOD from the for the Reporting on Health Collaborative

California prison officials say housed at two Central Valley prisons from valley fever is "premature" and urged a federal court to oppose its quick implementation.

“The [receiver’s] policy is ambiguous and in need of further clarification before it can be appropriately and effectively implemented,” the state Attorney General’s Office said on behalf of California Correctional Health Care Services in documents filed Monday in San Francisco's U.S. District Court.

The court is scheduled to hear arguments on June 17.

For Gov. Jerry Brown, the case represents a collision of two decades-long issues -- state prison overcrowding and the failure of federal and state officials to address treatments or a vaccine for coccidioidomycosis, known informally as "cocci" or valley fever.

People contract valley fever when they inhale spores of a fungus that is prevalent in the Southwestern United States. Farmers, construction workers and others who work outside are most likely to the disease and studies have shown that African Americans and Filipinos are unusually susceptible.

Most people who contract valley fever develop temporary flu or cold-like symptoms. However, in some people, especially those with compromised immune systems stemming from HIV or other illnesses, the disease can cause severe sickness and even death.

The disease has reached epidemic proportions in California's Central Valley over the past decade and has hit the state's prison population in that area particularly hard. Prisoners are vulnerable both because they are more likely to have chronic diseases like HIV and diabetes, and because they are often coming from outside the geographic area and have not developed immunity to the fungus.

For more than a year, the Reporting on Health Collaborative, which involves seven California news outlets, on the issue. The reporting revealed that valley fever has become a "" for some inmates.

Prison overcrowding in general compounds the problems that valley fever presents. Overcrowding and poor medical care forced the California prison system into federal receivership in 2006. Among other things, the receiver, J. Clark Kelso, is requiring that the system reduce the population of its 33 adult prisons to about 110,000 by the end of the year. The state's prison population has topped 170,000 in recent years.

Kelso has also adopted a valley fever policy in recent weeks that applied to prisoners at Pleasant Valley State Prison in Coalinga in Fresno County and Avenal State Prison in Kings County, both in the heart of valley fever territory.

Kelso is arguing that California has been too slow to act in protecting prisoners against valley fever, including dragging its feet in consulting both federal and state health officials.

“In the face of the State’s anemic response, the Receiver undertook his own analysis to address the cocci issue and, among other things, requested assistance from CDC [federal Centers for Disease Control and Prevention] and NIOSH [National Institute for Occupational Safety & Health],” according to a May 1 court filing by Kelso.

“Within days,” the filing said, “CDC and NIOSH staff ed the Receiver to begin determining what resources would be necessary and available for this analysis.”

Kelso's policy requires the state to exclude from those two prisons any inmate with a greater than 50 percent chance of contracting valley fever and inmates with general health problems who would face a significantly increased risk of dying if they contracted the disease. That includes inmates with HIV, diabetes, those undergoing chemotherapy, or who are pregnant.

Currently, there are about 8,200 inmates at the two prisons and an official from the California Department of Corrections and Rehabilitation estimated about one third of them would be affected in some way by the receiver’s policy.

“The receiver is calling for the transferring, and he described it last week as ‘effective immediately,’ of over 3,000 inmates from those two prisons,” said Corrections Department spokesman Jeffrey Callison in an interview Tuesday on radio station KVPR in Fresno with reporter Rebecca Plevin.

 “That’s a huge, complex undertaking,” Callison said. “Could it happen? Of course it could happen, but it would take a long time to implement because it’s very complicated.”

In addition, according to a statement issued by the Corrections Department, it already has transferred dozens of high-risk inmates from the two prisons and has suspended the transfer of certain high-risk inmates into those prisons.

Image by Renette Stowe via

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES

Valley fever medication poses added risk for pregnant women

Research suggests an alarming link between a common drug used for valley fever and birth defects. The disease also tends to be more severe in pregnant women.

Legislation caps momentous year in battle against valley fever

Recently signed legislation capped a big year for efforts to combat a regional disease long overlooked by lawmakers.

For valley fever survivors, a growing need: wigs

The antifungal drugs used to treat valley fever can cause hair loss. With the number of valley fever cases on the rise, a wig shop in Bakersfield, Calif., is helping women feel better about themselves.

California budget boosts funding for valley fever

The budget includes $8 million for research and outreach into the disease, caused by inhaling spores that grow in arid soil.

Three valley fever bills sail through committee, one pulled by sponsor

Facing pushback from the medical community, California Assemblyman Vince Fong withdrew a bill late last month that would have required doctors to order specific types of lab tests when they suspect valley fever.

Assemblymen ask state for $7 million in fight against valley fever to fuel research, spread awareness

Bakersfield Assemblymen Vince Fong and Rudy Salas submitted a $7 million budget proposal that, if approved, would be the largest amount of money California has ever designated to research and raise awareness of the disease.

One year after federal health officials launch first-of-its-kind valley fever drug trial, few have enrolled

Just 48 people have signed up across California and Arizona for a new clinical trial of Fluconazole, an antifungal drug used to treat valley fever. That's far fewer than officials had expected.

Bakersfield legislators ask state for $3M in fight against valley fever

Bakersfield lawmakers requested $3 million in the state budget last week to research treatments and conduct outreach for valley fever.
сиалис купить с доставкой

www.pharmacy24.com.ua

варденафил цена